The evolution of iPSC-based cell therapy across autologous and allogeneic pathways

Anmin Wang, Yunpei Zhang, Hongkui Deng, Mingxia Gu

Open source

DOI
10.1016/j.xcrm.2026.102992
Published
2026-08
Container
Cell Reports Medicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.xcrm.2026.102992,
  title = {The evolution of iPSC-based cell therapy across autologous and allogeneic pathways},
  author = {Anmin Wang and Yunpei Zhang and Hongkui Deng and Mingxia Gu},
  year = {2026},
  journal = {Cell Reports Medicine},
  doi = {10.1016/j.xcrm.2026.102992},
  url = {https://doi.org/10.1016/j.xcrm.2026.102992}
}

RIS

TY  - JOUR
TI  - The evolution of iPSC-based cell therapy across autologous and allogeneic pathways
AU  - Anmin Wang
AU  - Yunpei Zhang
AU  - Hongkui Deng
AU  - Mingxia Gu
PY  - 2026
JO  - Cell Reports Medicine
DO  - 10.1016/j.xcrm.2026.102992
UR  - https://doi.org/10.1016/j.xcrm.2026.102992
ER  - 

APA

Wang, A., Zhang, Y., Deng, H., & Gu, M. (2026). The evolution of iPSC-based cell therapy across autologous and allogeneic pathways. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2026.102992

Source records